Let’s face it, the landscape of companies developing SaaS and data solutions for life sciences is crowded, ever-changing, and marked by fierce competition. For example, there are hundreds of SaaS products in the market supporting clinical trials, all of them vying for the same R&D budgets. To gain market share and increase valuation, companies are seeking new ways to maximize valuable resources and streamline operations.
One promising trend is fractional marketing: a strategic approach that lets life science SaaS and data companies leverage top-tier B2B marketing expertise on a part-time basis. This trend is particularly relevant as companies navigate economic headwinds, a challenging funding environment, and the need for industry knowledge to strengthen the marketing function.
Fractional marketing, which is gaining momentum in life sciences technology, is not a new model. This approach involves onboarding seasoned marketing executives and specialized teams part-time, providing startups and high-growth businesses with access to expertise without the financial burden of full-time employees. This is appealing to the life sciences tech, data and analytics landscape where innovation and speed to market are critical.
“Staffing marketing teams solely with full-time employees has become less viable, prompting interest in more flexible staffing models.”
Tighter capital markets have made it difficult for many life sciences SaaS and data companies to secure funding. As a result, staffing marketing teams solely with full-time employees has become less viable, prompting interest in more flexible staffing models. Prolonged (and often unsuccessful) searches for marketers with experience in both life sciences and technology is accelerating this shift. According to a recent article in BioSpace, companies are opting to leave executive positions vacant, spreading responsibilities across existing teams or hiring fractional leaders to manage critical functions like marketing. This lean approach helps companies preserve capital while still driving essential initiatives.
The trend is expanding beyond leadership positions like fractional CMOs. Onboarding fractional teams with life sciences and B2B marketing experience allows commercial teams to place the right talent, in the right seat, at the right time, for the right duration. This approach aligns marketing talent with commercial objectives and helps de-risk marketing from the burden of funding full-time salaries.
Ellen Reilly, CEO of Sware, a startup with a SaaS software validation solution for life sciences companies and software developers, explains the advantages of adopting a lean, fractional marketing team led by a trusted CMO:
“Hiring full-time marketing talent in the past didn’t work out. But partnering with an experienced fractional marketing team has helped Sware increase market impact while creating operational efficiencies. The fractional CMO has served as a member of my staff while a flexible team has created new messaging, improved market presence, and generated leads for sales. Fractional marketing was the right choice for our business at this stage of our growth.”
For life science tech and data companies considering fractional marketing, understanding the strategic application of this model is critical. Transitioning to fractional marketing involves more than just hiring part-time marketers; it requires a systematic approach to integrate these professionals into the existing commercial organization.
Life science tech and data companies that embrace fractional marketing must establish clear KPIs in alignment with the overall business objectives. These metrics could include social media engagement and website traffic, the number of qualified leads generated by marketing, and the return on investment from marketing programs.
The adoption of a fractional marketing model offers several advantages for life sciences tech companies:
A global leader in clinical trial technology and services made a major acquisition to complement its offerings. The combined enterprise needed to ensure continuity of in-market activities to meet commercial targets while introducing a new brand and integrating two marketing organizations.
By hiring a fractional marketing team, the company:
This example underscores the financial and operational benefits of adopting a fractional approach in the life sciences sector.
As life sciences evolves, so will the ways in which service providers engage with this industry. These trends are broadening interest in fractional marketing:
“By selecting a B2B marketing partner that specializes in integrating fractional teams into your organization, growth companies can achieve greater market impact, increased sales, and improved valuation.”
Fractional marketing represents a strategic, flexible and accelerated approach for life sciences tech and data companies to enhance the value of marketing, from improving market presence to driving pipeline. The right B2B marketing partner seamlessly integrates a fractional team with a client, helping growth companies achieve greater market impact, increase sales, and improve valuation. The future of fractional marketing for life sciences SaaS and data companies looks promising, with advancements in technology and a growing pool of professionals working in this model driving adoption and relevance.

To make sure you get accurate and helpful information, this guide has been edited and fact-checked by the Rebound Editorial Team.
Founder and CEO of Rebound
Take control of your content – ditch the algorithm and rely on our email newsletter for the latest best practices, trends, and resources.